Both of these receptors have displayed involvement in nociceptive responses associated with TRPV1 involvement, and they concurrently display positive tendencies in the treatment of EA for conditions of chronic pain and depression [65,66]. This evidence concerns the gene TRPV1 and depressive symptom measurement.